Aphria Inc (TSX:APHA) vs. CannTrust Holdings Inc (TSX:TRST): Which Should You Buy?
The Motley Fool
Published Nov 12, 2018 12:00
Updated Nov 12, 2018 12:15
For cannabis investors, the TSX has many options to choose from. But you wouldn’t know it if you only paid attention to headlines. Despite the grab bag of cannabis stocks trading on the TSX, Canopy Growth and Aurora Cannabis tend to hoard the lion’s share of attention.
But that’s no reason to stop your search there. In fact, if you’re willing to dig a little, you may find some worthy picks among small-cap pot stocks.
Two of the best are Aphria (TSX:APHA)(NYSE:APHA) and CannTrust Holdings (TSX:TRST). Both of these stocks have the strong revenue growth you’d expect from the cannabis industry, but also some other features that their larger peers can’t match.
However, these two small-cap cannabis stocks are not equal. For investors who’d prefer to buy just one, it helps to understand the differences between them. We can start by looking at their business models.
Business models
Both Aphria and CannTrust sell medical and recreational cannabis products. These offerings include cannabis flower and oils. CannTrust also offers capsules.
One difference between Aphria and CannTrust is their level of international focus. Aphria has placed a much greater emphasis on international expansion than CannTrust has, with more international acquisitions and a greater international presence. This means that CannTrust’s earnings will be affected more by legalization, because Aphria’s sales are spread out more across the globe.
Profitability metrics
When it comes to profitability, CannTrust has Aphria (and most other cannabis stocks) beat. In its most recent quarter it posted a net income of about $100,000, compared to a $5 million loss for Aphria. CannTrust’s operating income was much higher than its net income for the quarter at about $2.5 million. I think that operating income is a closer approximation of true earnings for CannTrust than net income, since the net figure for Q2 included a deferred income tax expense.
Growth metrics
Both Aphria and CannTrust are strong growth stocks, with revenue growth well into the double digits. Aphria has a slight edge over CannTrust when it comes to growth, with a 117% growth rate in the last quarter compared to CannTrust’s 99%. In terms of earnings growth, both Aphria and CannTrust were down in their most recent quarters, which means costs are outpacing revenue.
Get The App
Year-to-date performance
In terms of year-to-date performance, both Aphria and CannTrust are currently in the red. Both of them staged impressive rallies in late summer, driven by the sector-wide explosion after Canopy’s $5 billion acquisition. And both of them fell later with October’s cannabis carnage.
CannTrust is down slightly less than Aphria at 5% for the former vs. 20% for the latter. I don’t think Aphria’s bigger year-to-date loss necessarily means much, since both of these stocks’ prices were disproportionately impacted by macro factors beyond their control.
Bottom line
Aphria and CannTrust are smaller than some of their peers in the cannabis industry, but they have some impressive metrics nonetheless. CannTrust is by far the most profitable pot stock (although its earnings are trending down), while Aphria sports some mighty impressive revenue growth. Between the two, I’d pick CannTrust, just because its operations are more profitable and it isn’t overleveraging its balance sheet out of “acquisition fever.”
Fool contributor Andrew Button has no position in any of the stocks mentioned.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.